0001209191-23-024305.txt : 20230414
0001209191-23-024305.hdr.sgml : 20230414
20230414161439
ACCESSION NUMBER: 0001209191-23-024305
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230412
FILED AS OF DATE: 20230414
DATE AS OF CHANGE: 20230414
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SACHS BRUCE I
CENTRAL INDEX KEY: 0001197036
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 23821307
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-12
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197036
SACHS BRUCE I
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVE
BOSTON
MA
02210
1
0
0
0
1
Common Stock
2023-04-12
4
M
0
21300
72.14
A
62510
D
Common Stock
2023-04-12
4
S
0
2917
325.65
D
59593
D
Common Stock
2023-04-12
4
S
0
10357
326.46
D
49236
D
Common Stock
2023-04-12
4
S
0
8026
327.48
D
41210
D
Common Stock
2023-04-13
4
G
0
1210
0.00
D
40000
D
Stock Option (Right to Buy)
72.14
2023-04-12
4
M
0
21300
0.00
D
2024-05-31
Common Stock
21300
0
D
Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1, which was entered into on 11/04/2022.
Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $325.65 (range $325.00 to $325.99).
Open market sales reported on this line occurred at a weighted average price of $326.46 (range $326.00 to $326.97).
Open market sales reported on this line occurred at a weighted average price of $327.48 (range $327.00 to $327.93).
Fully vested
/s/Christiana Stevenson, Attorney-in-Fact
2023-04-14